Frankel IHBH Inaugural Postdoctoral Fellowship Award 2026

Aurel Leuchtmann, Ph.D., working in lab

The Stanley and Judith Frankel Institute for Heart and Brain Health (Frankel IHBH) is proud to announce Aurel B. Leuchtmann, Ph.D., as the inaugural Frankel IHBH Postdoctoral Fellow. Awarded annually to an outstanding postdoctoral researcher pursuing innovative work in heart or brain health, this fellowship supports his research conducted under the mentorship of Jorge L. Ruas, Pharm.D., Ph.D., Professor of Pharmacology at the University of Michigan.

Aurel Leuchtmann, Ph.D.
Aurel Leuchtmann, Ph.D.

Dr. Leuchtmann is a molecular biologist whose research focuses on understanding how tissues adapt to physiological and pathological stress, directly aligned with the Frankel IHBH’s approach to advance heart and brain health. He completed his training in Switzerland at ETH Zurich (B.S., M.S.) and the Biozentrum, University of Basel (Ph.D.), where he investigated molecular mediators of exercise-training adaptations in young and aged musculoskeletal tissues. This work built his expertise in molecular exercise physiology, tissue-specific and systemic aging, muscle proteomics, and in vivo mouse models.

In the Ruas lab at UM, Dr. Leuchtmann studies the molecular and cellular mechanisms underlying cardiac dysfunction, with a focus on identifying early biomarkers and defining key drivers of disease progression. His research aims to inform both pharmacological and non-pharmacological approaches to prevent, halt, or reverse pathological remodeling of the heart.

Featured News & Stories

Liu Lab Image
Research News

CPOD Faculty Publication Spotlight - Liu Lab

In the February 2026 issue of Bone, the Liu Lab published "Loss of Tsc1 in Osterix-expressing cells leads to greater bone mass and strength in mice."
Department News

U-M Awards Strategic Initiative Fund Grant to Diabetes Reprogramming Initiative Led by Dr. Ganesh Palapattu

Dr. Ganesh Palapattu's Michigan Initiative to Reprogram Cells for Diabetes (MIRC-D) has been selected for funding through the University of Michigan's Strategic Initiative Fund, supporting innovative, multidisciplinary research aimed at transforming diabetes treatment.
Breathe 3 Pulm Group
Department News

BREATHE-3 study offers lifeline to Michigan patients with severe emphysema

University of Michigan researchers have treated the state's first COPD patient with the investigational Apreo BREATHE Airway Scaffold as part of the BREATHE-3 study. The technology reshapes diseased airways to reduce trapped air, offering a new option for severe emphysema patients who do not qualify for traditional treatments.
family together celebrating birthday
Health Lab

Specialized care helps patient navigate rare liposarcoma diagnosis

Specialized care helps a Michigan Medicine patient navigate a rare liposarcoma diagnosis.
Department News

Medical School Honors Three Faculty Members with Endowed Professorships

The University of Michigan Medical School celebrates Dr. Salami, Dr. Kraft and Dr. Gupta on receiving endowed professorships, one of the institution’s highest faculty honors.
Photo of Mathew Innes
Office of Research

Mathew Innes Appointed Director for Clinical Research

The Medical School Office of Research (OoR) is pleased to announce the appointment of Mathew Innes, MBA, as the Director for Clinical Research in the Medical School Office of Research, effective Tuesday, September 1, 2026.